Pages
Posts by category
- Category: ניוזלטר
- Category: עדכונים
- Category: Article
- Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, openlabel, blinded-endpoint trial (12/31/2022)
- IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency (01/31/2022)
- The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial (12/31/2021)
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (09/21/2021)
- Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF (06/30/2021)
- Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial (04/25/2021)
- 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction (02/28/2021)
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (12/31/2020)
- WHO GUIDELINE ON USE OF FERRITIN CONCENTRATIONS TO ASSESS IRON STATUS IN INDIVIDUALS AND POPULATIONS (05/09/2020)
- Effect of intravenous iron replacement therapy on exercise capacity in iron deficient anemic patients after cardiac surgery (03/31/2020)
- Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials (06/30/2018)
- Review Article: Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions (04/05/2018)
- Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function (02/28/2018)
- Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial (05/31/2017)
- Effects of intravenous iron therapy in iron‐deficient patients with systolic heart failure: a meta‐analysis of randomized controlled trials (07/31/2016)
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency (08/27/2015)
- Cost-effectiveness of heart failure therapies (08/27/2015)
- Iron-deficiency anemia (05/27/2015)
- Safety of Ferric Carboxymaltose Immediately after Infliximab Administration, in a Single Session, in Inflammatory Bowel Disease Patients with Iron Deficiency: A Pilot Study (05/27/2015)
- European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases (03/27/2015)
- The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study (02/27/2015)
- Intravenous ferric carboxymaltose for anaemia in pregnancy (03/27/2014)
- Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia – systematic review and meta-analysis of randomised controlled trials (01/29/2013)
- Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK (07/27/2012)
- Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose (05/29/2012)
- Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron (05/29/2012)
- Safety and efficacy of high-dose intravenous iron carboxymaltose vs. iron sucrose for treatment of postpartum anemia (04/29/2012)
- FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease (09/29/2011)
- Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds (08/19/2010)
- The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review (05/29/2010)
- Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment (06/29/2009)
- The pharmacology and safety profile of ferric carboxymaltose (Ferinject®): structure/reactivity relationships of iron preparations (01/31/2009)
- A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial (05/29/2008)
- Category: הודעות חדשות
- Category: מחקרים ופירסומים